Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECG studies with astemizole.

T M Craft1, G Vanden Bussche, J De Cree

  • 1Department of Anaesthesia and Intensive Care, Milton Keynes, Bucks, UK.

Human Toxicology
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guaranteeing drug delivery during total intravenous anaesthesia.

Anaesthesia·2015
Same author

Use of the ECG-triggered Venous Occlusion Plethysmograph to Study Hyperæmic Response Patterns in Patients with Intermittent Claudication treated with Cinnarizine.

Proceedings of the Royal Society of Medicine·2010
Same author

Use of the ProSeal LMA in the ICU to facilitate weaning from controlled ventilation in patients with severe two episodic bronchospasm.

European journal of anaesthesiology·2006
Same author

An evaluation of the flexiguide introducer with the flexible laryngeal mask airway.

Anaesthesia and intensive care·2003
Same author

Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type.

Neurochemistry international·1999
Same author

Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.

Cardiovascular drugs and therapy·1998

This study found that astemizole, an antihistamine, did not affect heart rate, blood pressure, or ECG in healthy volunteers. Astemizole safety is supported by these findings.

Area of Science:

  • Pharmacology
  • Cardiovascular Safety

Background:

  • Astemizole is an antihistamine used for allergies.
  • Understanding its cardiovascular effects is crucial for patient safety.

Purpose of the Study:

  • To evaluate the haemodynamic safety of astemizole in healthy volunteers.
  • To assess the impact of astemizole on cardiovascular parameters.

Main Methods:

  • A 2-week study involving six healthy volunteers.
  • Administered astemizole at 30 mg/day for 3 days, then 10 mg/day for 12 days.
  • Monitored heart rate, blood pressure, ECG, and systolic time intervals.

Main Results:

  • No significant changes were observed in measured haemodynamic parameters.

Related Experiment Videos

  • Electrocardiogram (ECG) configuration remained unaffected.
  • Serum astemizole metabolite concentrations were substantially lower than in overdose cases.

    • Conclusions:

    • Astemizole demonstrated a favourable haemodynamic safety profile in this study.
    • The drug did not induce adverse cardiovascular effects at the tested dosages.
    • Findings support the safety of astemizole in clinical use.